- Home
- BCAX vs JELD Comparison
BCAX vs JELD Comparison
Compare BCAX & JELD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCAX
- JELD
- Stock Information
- Founded
- BCAX 2018
- JELD 1960
- Country
- BCAX United States
- JELD United States
- Employees
- BCAX N/A
- JELD N/A
- Industry
- BCAX
- JELD Forest Products
- Sector
- BCAX
- JELD Basic Materials
- Exchange
- BCAX NYSE
- JELD Nasdaq
- Market Cap
- BCAX 1.0B
- JELD 908.0M
- IPO Year
- BCAX 2024
- JELD 2017
- Fundamental
- Price
- BCAX $16.35
- JELD $9.29
- Analyst Decision
- BCAX Strong Buy
- JELD Hold
- Analyst Count
- BCAX 5
- JELD 10
- Target Price
- BCAX $41.33
- JELD $14.56
- AVG Volume (30 Days)
- BCAX 342.9K
- JELD 601.2K
- Earning Date
- BCAX 11-12-2024
- JELD 11-04-2024
- Dividend Yield
- BCAX N/A
- JELD N/A
- EPS Growth
- BCAX N/A
- JELD N/A
- EPS
- BCAX N/A
- JELD N/A
- Revenue
- BCAX N/A
- JELD $3,900,923,000.00
- Revenue This Year
- BCAX N/A
- JELD N/A
- Revenue Next Year
- BCAX N/A
- JELD N/A
- P/E Ratio
- BCAX N/A
- JELD N/A
- Revenue Growth
- BCAX N/A
- JELD N/A
- 52 Week Low
- BCAX $17.00
- JELD $8.90
- 52 Week High
- BCAX $28.09
- JELD $21.75
- Technical
- Relative Strength Index (RSI)
- BCAX N/A
- JELD 29.12
- Support Level
- BCAX N/A
- JELD $10.13
- Resistance Level
- BCAX N/A
- JELD $10.79
- Average True Range (ATR)
- BCAX 0.00
- JELD 0.30
- MACD
- BCAX 0.00
- JELD 0.02
- Stochastic Oscillator
- BCAX 0.00
- JELD 2.26
About BCAX BICARA THERAPEUTICS INC
Bicara Therapeutics Inc is a clinical-stage biopharmaceutical company bringing transformative bifunctional therapies to patients with solid tumors. Its program ficerafusp alfa is a bifunctional antibody that combines two clinically validated targets, an epidermal growth factor receptor, or EGFR, directed monoclonal antibody with a domain that binds to human transforming growth factor beta, or TGF-b.
About JELD JELD-WEN Holding Inc.
JELD-WEN Holding Inc is engaged in door and window manufacturing. The company designs, produces, and distributes interior and exterior building products, offering a selection of doors, windows, walls, and related products. The products are used in the new construction of residential single and multi-family homes and non-residential buildings. The firm's operating segments are North America, Europe, and Australasia. It generates a majority of its revenue from North America.